We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+24.68%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.51B
AUM Growth
+$758M
Cap. Flow
+$605M
Cap. Flow %
17.25%
Top 10 Hldgs %
47.4%
Holding
285
New
108
Increased
67
Reduced
35
Closed
69

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$28.2M
2
ALGN icon
Align Technology
ALGN
+$19.3M
3
APR
Apria, Inc. Common Stock
APR
+$17.3M
4
CUTR
Cutera, Inc.
CUTR
+$14.8M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$13M

Top Sells

Rank Stock Value
1
VCEL icon
Vericel Corp
VCEL
+$14.4M
2
AFIB
Acutus Medical Inc
AFIB
+$13.5M
3
SHC icon
Sotera Health
SHC
+$12.9M
4
OPCH icon
Option Care Health
OPCH
+$12.1M
5
BNGO icon
Bionano Genomics
BNGO
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33%
2 Industrials 1.49%
3 Materials 0.46%
4 Financials 0.45%
5 Consumer Staples 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPRY icon
251
ARS Pharmaceuticals
SPRY
$601M
– –
-45,000
Closed -$2.08M
SRPT icon
252
CALL
Sarepta Therapeutics
SRPT
$1.94B
– –
-84,000
Closed -$14.3M
SRPT icon
253
PUT
Sarepta Therapeutics
SRPT
$1.94B
– –
-40,000
Closed -$6.82M
STE icon
254
PUT
Steris
STE
$23.1B
– –
-46,500
Closed -$8.81M
SYK icon
255
PUT
Stryker
SYK
$133B
– –
-70,000
Closed -$17.2M
TGTX icon
256
TG Therapeutics
TGTX
$7.58B
– –
-23,029
Closed -$1.2M
TWST icon
257
PUT
Twist Bioscience
TWST
$7.85B
– –
-69,700
Closed -$9.85M
VEEV icon
258
PUT
Veeva Systems
VEEV
$39.2B
– –
-25,000
Closed -$6.81M
VTGN icon
259
VistaGen Therapeutics
VTGN
$11.6M
– –
-48,611
Closed -$2.83M
WGS icon
260
GeneDx Holdings
WGS
$2.46B
– –
-7,273
Closed -$2.65M
XRAY icon
261
PUT
Dentsply Sirona
XRAY
$2.27B
– –
-206,000
Closed -$10.8M
ZYXI
262
PUT
DELISTED
Zynex
ZYXI
– –
-147,070
Closed -$1.8M
NVRO
263
CALL
DELISTED
NEVRO CORP.
NVRO
– –
-15,000
Closed -$2.6M
NVRO
264
PUT
DELISTED
NEVRO CORP.
NVRO
– –
-44,500
Closed -$7.7M
AXNX
265
PUT
DELISTED
Axonics, Inc. Common Stock
AXNX
– –
-100,000
Closed -$4.99M
HA
266
CALL
DELISTED
Hawaiian Holdings, Inc.
HA
– –
-250,000
Closed -$4.42M
SILK
267
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
– –
-98,400
Closed -$6.2M
MORF
268
DELISTED
Morphic Holding, Inc. Common Stock
MORF
– –
-50,000
Closed -$1.68M
AFIB
269
DELISTED
Acutus Medical Inc
AFIB
– –
-473,146
Closed -$13.5M
NSTG
270
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-239,300
Closed -$16M
GTH
271
DELISTED
Genetron Holdings Limited ADS
GTH
– –
-88,967
Closed -$3.74M
CELL
272
DELISTED
PhenomeX Inc. Common Stock
CELL
– –
-26,600
Closed -$2.38M
HARP
273
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
– –
-1,020
Closed -$169K
SGTX
274
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
– –
-1,902
Closed -$1.19M
CNCE
275
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-293,443
Closed -$3.71M
8 9 10
11
12

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2021 Portfolio in Review

As of Q1 2021, Pura Vida Investments held 285 positions worth $3.51B, up 28% from $2.75B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pura Vida Investments deployed $605M of net new capital in Q1 2021, opening 108 new positions and adding to 67 existing holdings. Its largest new stake was Align Technology: 35,000 shares worth $19M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Industrials and Materials.

On the sell side, the largest reduction was Vericel Corp, an estimated $14.4M trimmed.

  • Pura Vida Investments's largest Q1 2021 buy was Align Technology: 35,000 shares worth $19M.
  • Pura Vida Investments added most to Insight Molecular Diagnostics in Q1 2021, an estimated $28.2M increase.
  • Pura Vida Investments's biggest Q1 2021 reduction was Vericel Corp, cutting an estimated $14.4M.
  • Pura Vida Investments fully exited Acutus Medical Inc in Q1 2021, selling an estimated $13.5M.
  • Pura Vida Investments's ten largest holdings make up 47% of its $3.51B portfolio in Q1 2021.
  • Pura Vida Investments opened 108 new positions and closed 69 in Q1 2021.
  • Pura Vida Investments's portfolio value rose 28% quarter-over-quarter to $3.51B.

Based on Pura Vida Investments's 13F filing for Q1 2021, filed 12 May 2021.